A
$ Value
—
Shares
19,108
Price
—
Filed
Jul 7
Insider
Name
Baxter Richard B
Title
—
CIK
0002075922
Roles
Director
Transaction Details
Transaction Date
2025-07-02
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
19,108
Footnotes
On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 19,108 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis thereafter over a period of three (3) years. | On July 2, 2025, the Reporting Person was granted stock options to purchase 58,230 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis thereafter over a period of three (3) years.
Filing Info
Baxter Richard B's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-07-02 | PTHS | A | $0 |
| 2025-07-02 | PTHS | A | — |
| 2025-07-02 | PTHS | A | — |
Other Insiders at PTHS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Greenleaf Peter | — | $17K | 2026-04-02 |
| Davis Todd C | — | — | 2025-07-02 |
|
Francis Knuettel II
CFO, Treas & Secty
|
— | — | 2025-07-02 |
| Pauls Matthew | — | $16K | 2026-04-02 |
| Friedberg Ezra M | — | $12K | 2026-04-02 |
|
Plesha Scott M.
CEO and President
|
— | — | 2025-07-02 |
| Malamut Richard | — | $12K | 2026-04-02 |
| Baxter Richard B | — | — | 2025-07-02 |
|
Rangarao Sai
Chief Commercial Officer
|
— | — | 2025-07-02 |